• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血干细胞移植结果登记处的当前概念;对新登记处资源需求的强调。

Current concepts on hematopoietic stem cell transplantation outcome registries; Emphases on resource requirements for new registries.

作者信息

Hussain Fazal, Chaudhri Naeem, Alfraih Feras, Aljurf Mahmoud

机构信息

Oncology Center, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

Oncology Center, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

出版信息

Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):203-210. doi: 10.1016/j.hemonc.2017.05.011. Epub 2017 Jul 19.

DOI:10.1016/j.hemonc.2017.05.011
PMID:28751034
Abstract

There is tremendous variability in size, scope, and resource requirements for registries depending on the number of patients and participating sites. The outcome registries are organized systems to collect uniform data using an observational study methodology. Patient registries are used to determine specified outcomes for a population for predetermined scientific, clinical, or policy purposes. Historically, outcome registries established in the development of hematopoietic stem cell transplantation (HSCT) have now evolved into myriads of locoregional and international transplant activity and outcome resources. Over time, these registries have contributed immensely in determining trends, patterns, and treatment outcomes in HSCT. There is wider variation in the goals, mission, objectives, and outcomes of the ongoing registries depending on the organizational structure. There is a growing trend toward overarching relationship of these registries to serve as complementary and interoperable resources for high potential collaborative research. In addition to capacity building, standardized, accredited, and optimally operational registries can provide unmatched and unparalleled research data that cannot be obtained otherwise. Moving forward, HSCT data collection, collation, and interpretation should be an integral part of the treatment rather than an option. Quality assurance and continuous quality improvement of the data are pivotal for credibility, measurable/quantifiable outcomes, clinically significant impact, and setting new benchmarks.

摘要

根据患者数量和参与站点的不同,登记处的规模、范围和资源需求存在巨大差异。结局登记处是使用观察性研究方法收集统一数据的有组织系统。患者登记处用于为特定人群确定预定科学、临床或政策目的的特定结局。从历史上看,造血干细胞移植(HSCT)发展过程中建立的结局登记处如今已演变成众多局部和国际移植活动及结局资源。随着时间的推移,这些登记处对确定HSCT的趋势、模式和治疗结局做出了巨大贡献。根据组织结构的不同,现行登记处的目标、使命、目的和结局存在更广泛的差异。这些登记处之间建立总体关系以作为高潜力合作研究的互补且可互操作资源的趋势日益增强。除了能力建设外,标准化、经认证且运行最佳的登记处能够提供通过其他方式无法获得的无与伦比的研究数据。展望未来,HSCT数据的收集、整理和解读应成为治疗的一个组成部分,而非一种选择。数据的质量保证和持续质量改进对于可信度、可测量/可量化的结局、临床显著影响以及设定新基准至关重要。

相似文献

1
Current concepts on hematopoietic stem cell transplantation outcome registries; Emphases on resource requirements for new registries.造血干细胞移植结果登记处的当前概念;对新登记处资源需求的强调。
Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):203-210. doi: 10.1016/j.hemonc.2017.05.011. Epub 2017 Jul 19.
2
Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts.造血干细胞移植结果登记处面临的挑战与机遇:国际造血干细胞移植登记处专家视角
Bone Marrow Transplant. 2014 Aug;49(8):1016-21. doi: 10.1038/bmt.2014.78. Epub 2014 Apr 28.
3
Data Management数据管理
4
Quality control and assurance in hematopoietic stem cell transplantation data registries in Japan and other countries.日本及其他国家造血干细胞移植数据登记处的质量控制与保证
Int J Hematol. 2016 Jan;103(1):20-4. doi: 10.1007/s12185-015-1896-8. Epub 2015 Nov 13.
5
Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System.日本造血干细胞移植登记处的统一及TRUMP系统的建立。
Int J Hematol. 2007 Oct;86(3):269-74. doi: 10.1532/IJH97.06239.
6
Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products.参与全球造血干细胞供者和产品交换的注册机构的标准、法规和认证。
Bone Marrow Transplant. 2010 May;45(5):819-24. doi: 10.1038/bmt.2010.8. Epub 2010 Feb 22.
7
Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004.1992 - 2004年澳大利亚和新西兰的造血干细胞移植
Biol Blood Marrow Transplant. 2007 Aug;13(8):905-12. doi: 10.1016/j.bbmt.2007.04.003. Epub 2007 May 23.
8
History of hematopoietic stem cell transplantation.造血干细胞移植史。
Semin Oncol Nurs. 2009 May;25(2):95-9. doi: 10.1016/j.soncn.2009.03.004.
9
[The unification of hematopoietic stem cell transplantation registry in Japan and establishment of the TRUMP system].[日本造血干细胞移植登记的统一与TRUMP系统的建立]
Rinsho Ketsueki. 2007 Nov;48(11):1462-9.
10
[Economic evaluation of the organization of a registry of haematopoietic stem cell donors].[造血干细胞捐献者登记组织的经济评估]
Rev Epidemiol Sante Publique. 2007 Aug;55(4):275-84. doi: 10.1016/j.respe.2007.04.002.

引用本文的文献

1
Artificial Intelligence Approaches in Hematopoietic Cell Transplantation: A Review of the Current Status and Future Directions.造血细胞移植中的人工智能方法:现状与未来方向综述
Turk J Haematol. 2018 Aug 3;35(3):152-157. doi: 10.4274/tjh.2018.0123. Epub 2018 Jun 8.